Maria Fardis

US·SEC (Form 4)

Iovance Biotherapeutics, Inc.Pharmacyclics Inc

Cumul. flow

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (6 ops.)

€1.8M

Latest filing published 02 Jun 2020 for Iovance Biotherapeutics, INC., €56k.

Insider track record

Disclosed buys

Disclosed sells

Signal history

Maria Fardis: trading record in brief

Maria Fardis is a declared insider at 2 companies; the most frequent names are Iovance Biotherapeutics, Inc. and Pharmacyclics Inc. Between 31 October 2012 and 1 June 2020, the trades on record add up to 54 filings.

Every open-market trade on record is a sale: 6 sales worth €1.8M. The rest of the record consists of 39 share grants and 5 option exercises.

Most recently, on 2 June 2020, the filings show a share grant worth €56k in Iovance Biotherapeutics, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Maria Fardis

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Iovance Biotherapeutics, Inc. (US)Pharmacyclics Inc (US)

Declarations51 total

◆
Maria Fardis
President and CEOExecutives1 Jun 2020Iovance Biotherapeutics, Inc.
62,729 USD22SEC
1,894 shares@ US$33.123.1% of flowCommon StockSEC:0001104659-20-069097:0
◆
Maria Fardis
President and CEOExecutives1 May 2020Iovance Biotherapeutics, Inc.
60,608 USD22SEC
1,894 shares@ US$32.003.0% of flowCommon StockSEC:0001104659-20-056429:0
◆
Maria Fardis
President and CEOExecutives1 Apr 2020Iovance Biotherapeutics, Inc.
41,742 USD22SEC
1,494 shares@ US$27.942.1% of flowCommon StockSEC:0001104659-20-043125:0
◆
Maria Fardis
President and CEOExecutives2 Mar 2020Iovance Biotherapeutics, Inc.
47,543 USD22SEC
1,321 shares@ US$35.992.3% of flowCommon StockSEC:0001104659-20-029218:0
◆
Maria Fardis
President and CEOExecutives3 Feb 2020Iovance Biotherapeutics, Inc.
29,347 USD22SEC
1,302 shares@ US$22.544.9% of flowCommon StockSEC:0001104659-20-011256:0
◆
Maria Fardis
President and CEOExecutives2 Jan 2020Iovance Biotherapeutics, Inc.
41,674 USD23SEC
1,562 shares@ US$26.686.9% of flowCommon StockSEC:0001104659-20-001682:0
◆
Maria Fardis
President and CEOExecutives1 Feb 2019Iovance Biotherapeutics, Inc.
14,464 USD22SEC
1,562 shares@ US$9.262.4% of flowCommon StockSEC:0001104659-19-070006:21
◆
Maria Fardis
President and CEOExecutives1 Mar 2019Iovance Biotherapeutics, Inc.
13,979 USD22SEC
1,298 shares@ US$10.772.3% of flowCommon StockSEC:0001104659-19-070006:22
◆
Maria Fardis
President and CEOExecutives1 Apr 2019Iovance Biotherapeutics, Inc.
12,919 USD22SEC
1,321 shares@ US$9.782.1% of flowCommon StockSEC:0001104659-19-070006:23
◆
Maria Fardis
President and CEOExecutives1 May 2019Iovance Biotherapeutics, Inc.
14,716 USD22SEC
1,321 shares@ US$11.142.4% of flowCommon StockSEC:0001104659-19-070006:24
◆
Maria Fardis
President and CEOExecutives2 Jan 2019Iovance Biotherapeutics, Inc.
14,761 USD22SEC
1,562 shares@ US$9.452.4% of flowCommon StockSEC:0001104659-19-070006:20
◆
Maria Fardis
President and CEOExecutives3 Apr 2017Iovance Biotherapeutics, Inc.
369,462 USD0SEC
51,673 shares@ US$7.15Common StockSEC:0001104659-19-070006:0
◆
Maria Fardis
President and CEOExecutives1 Jun 2017Iovance Biotherapeutics, Inc.
782,053 USD0SEC
143,496 shares@ US$5.45Common StockSEC:0001104659-19-070006:1
◆
Maria Fardis
President and CEOExecutives1 Jul 2017Iovance Biotherapeutics, Inc.
14,656 USD0SEC
1,994 shares@ US$7.35Common StockSEC:0001104659-19-070006:2
◆
Maria Fardis
President and CEOExecutives1 Aug 2017Iovance Biotherapeutics, Inc.
11,360 USD0SEC
1,993 shares@ US$5.70Common StockSEC:0001104659-19-070006:3
◆
Maria Fardis
President and CEOExecutives1 Sept 2017Iovance Biotherapeutics, Inc.
11,964 USD0SEC
1,994 shares@ US$6.00Common StockSEC:0001104659-19-070006:4
◆
Maria Fardis
President and CEOExecutives1 Oct 2017Iovance Biotherapeutics, Inc.
15,446 USD0SEC
1,993 shares@ US$7.75Common StockSEC:0001104659-19-070006:5
◆
Maria Fardis
President and CEOExecutives1 Nov 2017Iovance Biotherapeutics, Inc.
14,257 USD0SEC
1,994 shares@ US$7.15Common StockSEC:0001104659-19-070006:6
◆
Maria Fardis
President and CEOExecutives1 Dec 2017Iovance Biotherapeutics, Inc.
17,547 USD0SEC
1,994 shares@ US$8.80Common StockSEC:0001104659-19-070006:7
◆
Maria Fardis
President and CEOExecutives1 Jan 2018Iovance Biotherapeutics, Inc.
12,496 USD0SEC
1,562 shares@ US$8.00Common StockSEC:0001104659-19-070006:8
◆
Maria Fardis
President and CEOExecutives1 Feb 2018Iovance Biotherapeutics, Inc.
25,163 USD0SEC
1,525 shares@ US$16.50Common StockSEC:0001104659-19-070006:9
◆
Maria Fardis
President and CEOExecutives1 Mar 2018Iovance Biotherapeutics, Inc.
23,976 USD0SEC
1,321 shares@ US$18.15Common StockSEC:0001104659-19-070006:10
◆
Maria Fardis
President and CEOExecutives1 Apr 2018Iovance Biotherapeutics, Inc.
22,325 USD0SEC
1,321 shares@ US$16.90Common StockSEC:0001104659-19-070006:11
◆
Maria Fardis
President and CEOExecutives1 May 2018Iovance Biotherapeutics, Inc.
19,287 USD0SEC
1,321 shares@ US$14.60Common StockSEC:0001104659-19-070006:12
◆
Maria Fardis
President and CEOExecutives1 Jun 2018Iovance Biotherapeutics, Inc.
19,221 USD0SEC
1,321 shares@ US$14.55Common StockSEC:0001104659-19-070006:13

25 of 51 declarations

Maria Fardis

Insider track record

Maria Fardis: trading record in brief

Companies and markets linked to Maria Fardis

Similar companies

Related executives